PPARGC1A and ovarian carcinoma: PPARGC1A (PGC-1α) participates essentially in metabolic reprogramming involved in gluconeogenesis, fatty acid metabolism, and mitochondrial biogenesis and facilitates a flexible metabolic profile to benefit tumor cells overexpressing PPARGC1A in human epithelial ovarian cancer cells [109,110,111,112].